Mr. Deng was appointed as the non-executive Director of the Company on December 15, 2025. Mr. Deng has also been serving as a director of MicroPort CRM since November 2025, mainly responsible for participating in decision-making of important matters of our Group and the high-level oversight of the management and operations of our Group.

Mr. Deng has amassed extensive experience in research, investment, and management across the healthcare sector. Currently serving at Yunfeng Capital (云锋基金), Mr. Deng leads and participates in investments and cross-border transactions across multiple sectors including biopharmaceuticals, cell therapies, medical devices and healthcare services. He has spearheaded or played a key role in the investment and post-investment management of nearly 20 portfolio companies to date.

Mr. Deng graduated from Peking University Health Science Center (北京大学医学部) with a bachelor’s degree in July 2020. In the same month, he obtained a dual bachelor’s degree in economics from the National School of Development at Peking University (北京大学国家发展研究院). He obtained a master’s degree in finance from Fudan University (复旦大学) in June 2022.